Join
Live feed
·
INSIDERFilingvia Quantisnow
Lyell Immunopharma Inc. logo

New insider Innovative Cellular Therapeutics Holdings Ltd claimed ownership of 3,000,000 shares (SEC Form 3)

ByQuantisnow·Wall Street's wire, on your screen.
LYEL· Lyell Immunopharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LYEL (Lyell Immunopharma Inc.) and more on Quantisnow.